Titre:
  • Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Auteur:Condorelli, Rosaria; Mosele, F.; Verret, Benjamin; Bachelot, Thomas; Bedard, Philippe L; Cortes, Javier; Hyman, David D.M.; Juric, Dejan; Krop, Ian; Bieche, Ivan; Saura, Cristina; Sotiriou, Christos; Cardoso, Fatima; Loibl, Sibylle; Andre, Fabrice; Turner, Nicholas C
Informations sur la publication:Annals of oncology, 30, 3, page (365-373)
Statut de publication:Publié, 2019-03
Sujet CREF:Cancérologie
Hématologie
Mots-clés:breast cancer
genomic alterations
precision medicine
target prioritization
targeted therapies
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdz036
info:pii/5305018
info:scp/85064114526
info:pmid/30715161